Back to Directory
research logo

Neurocrine Biosciences | Company Profile

1/13/2026

Contact Information

👤
Neurocrine Biosciences
🏢
Neurocrine Biosciences
📍
6027 Edgewood Bend Ct, San Diego, California 92130, US

Industry & Market

Primary Industry
research
All Industries
researchbiotechnology
Location
San Diego, California, United States
Public Trading
NASDAQ: NBIX

Company Metrics

👥Total Employees
583
⚙️Engineering
46
💼Sales Team
71
📈Marketing
40
📅Founded
1992
💰Revenue
2.4B

Funding Information

Market Cap
$13.5B
Annual Revenue
$2,355,300,000
Publicly traded company

Headcount Distribution

Total Employees
583
Departments
19

By Department

Department Breakdown

Education
Operations
Sales
Engineering
Human Resources
Business Development
Others

Technology Stack

Analytics & Tracking

Google AnalyticsGoogle Tag Manager

Development

Bootstrap Framework

Video & Media

Vimeo

Email & Communication

Outlook
Total: 21 technologies

Keywords & Focus Areas

movement disorderscnsneurologyendocrinologyimmunologybiotechnologylife sciencesbiotechnology: biological products (no diagnostic substances)health carebiotechnology researchbiotech partnershipsneurobiologybrain health treatmentsservicesfda-approved drugsendocrine disorder treatmentsneuropharmacology innovationsneuroendocrinology researchbrain disease research programsbiotech research and development+10 more
30 total keywords

Neurocrine Biosciences

Overview

Neurocrine Biosciences, Inc. is a biopharmaceutical company based in San Diego, California, founded in 1992. The company focuses on developing and commercializing treatments for neurological, endocrine, and psychiatric disorders. It went public in 1996 and has since evolved into a leader in addressing unmet medical needs in these areas.

The company's flagship product is valbenazine (Ingrezza), which received FDA approval in 2017 for treating tardive dyskinesia, a neurological movement disorder. The organization is also engaged in research and development of innovative therapies for various conditions, including anxiety, depression, irritable bowel syndrome, obesity, and Alzheimer's disease. It collaborates with notable partners such as Janssen Pharmaceutica, Eli Lilly, GlaxoSmithKline, and AbbVie to enhance research and commercialization efforts.

Basic Information

Industryresearch
Founded1992
Revenue$2.4B
Headquarters6027 Edgewood Bend Ct, San Diego, California 92130, United States
LanguagesEnglish
Alexa Ranking

Contact Details

Key Focus Areas & Initiatives

  • Movement disorders research
  • CNS therapeutics development
  • Neurology and endocrinology innovation
  • Immunology and biotechnology partnerships
  • FDA-approved drugs and rare disease treatments
  • Collaborative R&D with industry leaders
  • Gene therapy for brain disorders
  • Clinical trials and pipeline management
  • Advanced neuropharmacology research
  • Innovative neurotherapeutics
  • Mental health and psychiatric disorder solutions
  • Neuroimmunology research programs
  • Precision medicine strategies
  • Biopharmaceutical development
  • Healthcare inclusivity and patient-centered care
  • Therapeutic areas covering chronic and unmet medical needs

Technologies Used

  • Adobe Media Optimizer
  • Bootstrap Framework
  • Cedexis Radar
  • DigitalOcean
  • Google Analytics
  • Google Cloud Hosting
  • Google Tag Manager
  • MailJet
  • Microsoft Azure Hosting
  • Microsoft Office 365
  • Mimecast
  • Mobile Friendly
  • Netlify
  • Outlook
  • React Redux
  • Remote
  • Salesforce
  • Vimeo
  • WP Engine
  • WordPress.org
  • Workday Recruit

Affiliated Organizations & Regional Branches

Need more information?

Find decision makers, more insights and contact information about this company on Bitscale

Try Bitscale Now

Schedule your demo now!

See how BitScale can supercharge your outbound sales in a 30-minute demo

SayData

© 2026 Bitscale. Featherflow Technology Pvt Ltd

LinkedInTwitterInstagramYouTube